UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000029288
Receipt No. R000033477
Scientific Title To evaluate the efficacy and safety of once-weekly DPP-4 inhibitor: Omarigliptin and the differences between Omarigliptin and once or twice-daily DPP-4 inhibitors for the treatment of type 2 diabetes
Date of disclosure of the study information 2017/09/29
Last modified on 2019/03/27 14:25:56

No. Disposal Last modified on Item of update
1 Insert 2017/09/25 22:57:00
2 Update 2018/09/26 22:42:50 Research ethics review
3 Update 2018/09/26 22:52:33 Recruitment status
Anticipated trial start date
Last follow-up date
4 Update 2018/09/26 22:54:48 Anticipated trial start date
5 Update 2019/03/27 14:25:56 Number of participants that the trial has enrolled

Contact us.